ok well i just did some more reading and number crunching.
this looks like it will double quite easily on the heads. at current prices this is like theft. i will opt for the leverage on the options. the 1-2 month outlook is very promising considering:
1) their statement they will see production this financial year (i.e. before june 30, thats like two weeks away)
2) upcoming float at 50 cents in july on its cousin should bring this to equality considering a) it will be cheaper than its cousin and b) even its cousin would be considered cheap - lol.
beyond 1-2 months and taking a longer timeframe is attractive as the sector is appealing and it gives investors the opportunity to benefit from the growth in India.
thanks for all the information on the thread guys, particularly Tibbs, SP3 and T4P
- Forums
- ASX - By Stock
- GUJ
- ok im trying to evaluate this
GUJ
gujarat nre resources nl
ok im trying to evaluate this, page-4
Featured News
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
Currently unlisted public company.
The Watchlist
NUZ
NEURIZON THERAPEUTICS LIMITED
Dr Michael Thurn, CEO & MD
Dr Michael Thurn
CEO & MD
SPONSORED BY The Market Online